ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Further evidence that MRI based measurement of midbrain neuromelanin may serve as a proxy measure of brain dopamine activity in psychiatric disorders.

Cameron S CarterPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.